The role of co-occurring disruptive behavior in the clinical presentation of children and adolescents with anxiety in the context of autism spectrum disorders

Child Psychiatry and Human Development

Volumn 43, Issue 5, 2012, Pages 734-746

  Storch, Eric A ^a,b   Arnold, Elysse B ^a   Jones, Anna M ^a   Ale, Chelsea M ^a   Wood, Jeffrey J ^c   Ehrenreich May, Jill ^d   Lewin, Adam B ^a,b   Mutch, P Jane ^a   Murphy, Tanya K ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Department of Biology   (United States)

Author keywords

Anxiety; Asperger's Syndrome; Assessment; Autism; Children; Comorbidity; Oppositional defiant disorder; Treatment

Indexed keywords

NEUROLEPTIC AGENT;

ADOLESCENT; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; CHILD; CHILD BEHAVIOR; COMORBIDITY; DRUG EFFECT; EARLY CHILDHOOD INTERVENTION; FAMILY RELATION; FEMALE; HUMAN; MALE; METHODOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; RISK ASSESSMENT; SOCIAL SUPPORT;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; ANXIETY; ATTENTION DEFICIT AND DISRUPTIVE BEHAVIOR DISORDERS; CHILD; CHILD BEHAVIOR; CHILD DEVELOPMENT DISORDERS, PERVASIVE; COMORBIDITY; EARLY INTERVENTION (EDUCATION); FAMILY RELATIONS; FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; RISK ASSESSMENT; SOCIAL SUPPORT;

EID: 84866262870     PISSN: 0009398X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10578-012-0294-1     Document Type: Article

References (55)

1. Sofronoff K, Attwood T, Hinton SA (2005) Randomised controlled trial of a CBT intervention for anxiety in children with Asperger syndrome. J Child Psychol Psychiatry 46(11):1152-1160
2. Wood JJ, Drahota A, Sze K, Har K, Chiu A, Langer DA (2009) Cognitive behavioral therapy for anxiety in children with autism spectrum disorders: a randomized, controlled trial. J Child Psychol Psychiatry 50(3):224-234
3. McCracken JT, McGough J, Shah B et al (2002) Risperidone in children with autism and serious behavioral problems. N Engl J Med 347(5):314-321
4. Nadeau J, Sulkowski ML, Ung D et al (2011). Treatment of anxiety in patients with Autism spectrum disorders. Neuropsychiatry 1:567-578
5. White SW, Oswald D, Ollendick T, Scahill L (2009) Anxiety in children and adolescents with autism spectrum disorders. Clin Psychol Rev 29(3):216-229
6. Muris P, Steerneman P, Merckelbach H, Holdrinet I, Meesters C (1998) Comorbid anxiety symptoms in children with pervasive developmental disorders. J Anxiety Disord 12(4):387-393
7. Leyfer OT, Folstein SE, Bacalman S et al (2006) Comorbid psychiatric disorders in children with autism: interview development and rates of disorders. J Autism Dev Disord 36(7):849-861
8. de Bruin EI, Ferdinand RF, Meester S, de Nijs PF, Verheij F (2007) High rates of psychiatric co-morbidity in PDD-NOS. J Autism Dev Disord 37(5):877-886
9. Green J, Gilchrist A, Burton D, Cox A (2000) Social and psychiatric functioning in adolescents with Asperger syndrome compared with conduct disorder. J Autism Dev Disord 30(4):279-293
10. Gadow KD, Devincent CJ, Drabick DA (2008) Oppositional defiant disorder as a clinical phenotype in children with autism spectrum disorder. J Autism Dev Disord 38(7):1302-1310
11. Mattila ML, Hurtig T, Haapsamo H et al (2010) Comorbid psychiatric disorders associated with Asperger syndrome/high-functioning autism: a community- and clinic-based study. J Autism Dev Disord 40:1080-1093
12. Sze K, Wood JJ (2007) Cognitive behavioral treatment of comorbid anxiety disorders and social difficulties in children with high-functioning autism: a case report. J Contemp Psychother 37:133-143
13. Lewin AB, Wood JJ, Gunderson S, Murphy TK, Storch EA (2011) Phenomenology of comorbid Autism Spectrum and obsessive-compulsive disorders among children. J Devel Phys Dis 23:543-553
14. Storch EA, Lewin AB, Geffken GR, Morgan JR, Murphy TK (2010) The role of comorbid disruptive behavior in the clinical expression of pediatric obsessive-compulsive disorder. Behav Res Ther 48:1204-1210
15. Almandil NB, Wong IC (2011) Review on the current use of antipsychotic drugs in children and adolescents. Arch Dis Child Educ Pract Ed 96:192-196
16. Correll CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, Malhotra AK (2009) Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA 302(16):1765-1773
17. Neuhut R, Lindenmayer JP, Silva R (2009) Neuroleptic malignant syndrome in children and adolescents on atypical antipsychotic medication: a review. J Child Adolesc Psychopharmacol 19(4):415-422
18. Drabick DA, Gadow KD, Loney J (2008) Co-occurring ODD and GAD symptom groups: sourcespecific syndromes and cross-informant comorbidity. J Clin Child Adolesc Psychol 37(2):314-326
19. Bubier JL, Drabick DA (2009) Co-occurring anxiety and disruptive behavior disorders: the roles of anxious symptoms, reactive aggression, and shared risk processes. Clin Psychol Rev 29(7):658-669
20. Storch EA, Merlo LJ, Larson MJ et al (2008) Impact of comorbidity on cognitive-behavioral therapy response in pediatric obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 47(5): 583-592
21. Geller DA, Biederman J, Stewart SE et al (2003) Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials? J Child Adolesc Psychopharmacol 13(Suppl 1):S19-S29
22. Langley AK, Lewin AB, Bergman RL, Lee JC, Piacentini J (2010) Correlates of comorbid anxiety and externalizing disorders in childhood obsessive compulsive disorder. Eur Child Adolesc Psychiatry 19:637-645
23. APA (2000) Diagnostic and statistical manual of mental disorders. American Psychiatric Association, Washington, DC
24. Silverman WK, Albano AM (1996) The anxiety disorders interview schedule for DSM-IV-child and parent versions. Graywinds Publications, San Antonio
25. Silverman WK, Saavedra LM, Pina AA (2001) Test-retest reliability of anxiety symptoms and diagnoses with the Anxiety disorders interview schedule for DSM-IV: child and parent versions. J Am Acad Child Adolesc Psychiatry 40(8):937-944
26. Wood JJ, Piacentini JC, Bergman RL, McCracken J, Barrios V (2002) Concurrent validity of the anxiety disorders section of the anxiety disorders interview schedule for DSM-IV: child and parent versions. J Clin Child Adolesc Psychol 31:335-342
27. RUPP (2002) The pediatric anxiety rating scale (PARS): development and psychometric properties. J Am Acad Child Adolesc Psychiatry 41(9):1061-1069
28. Storch EA, Wood JJ, Ehrenreich May J et al (in press). Convergent and discriminant validity and reliability of the pediatric anxiety rating scale in youth with Autism spectrum disorders. J Autism Dev Dis
29. National Institute of Mental Health (1985) Clinical global impression scale. Psychopharmacol Bull 21:839-844
30. Constantino J (2002) The social responsiveness scale. Western Psychological Services, Los Angeles
31. March JS, Parker JD, Sullivan K, Stallings P, Conners CK (1997) The multidimensional anxiety scale for children (MASC): factor structure, reliability, and validity. J Am Acad Child Adolesc Psychiatry 36(4):554-565
32. Wood JJ, Piacentini JC, Bergman RL, McCracken J, Barrios V (2002) Concurrent validity of the anxiety disorders section of the anxiety disorders interview schedule for DSM-IV: child and parent versions. J Clin Child Adolesc Psychol 31(3):335-342
33. Achenbach T (2001) Manual for the ASEBA school-age forms & profiles. University of Vermont, Burlington
34. Bird H, Andrews H, Schwab-Stone M et al (1996) Global measures of impairment for epidemiologic and clinical use with children and adolescents. Int J Meth Psychiatric Res 6:295-307
35. Greenland S (1987) Interpretation and choice of effect measures in epidemiologic analyses. Am J Epidem 125:761-767
36. Barkley RA, Shelton TL, Crosswait C et al (2002) Preschool children with disruptive behavior: threeyear outcome as a function of adaptive disability. Dev Psychopathol 14:45-67
37. Langley AK, Bergman RL, McCracken J, Piacentini JC (2004) Impairment in childhood anxiety disorders: preliminary examination of the child anxiety impact scale-parent version. J Child Adolesc Psychopharmacol 14(1):105-114
38. Lecavalier L, Leone S, Wiltz J (2006) The impact of behaviour problems on caregiver stress in young people with autism spectrum disorders. J Intellect Disabil Res 50(Pt 3):172-183
39. Arnold LE, Farmer C, Kraemer HC et al (2010) Moderators, mediators, and other predictors of risperidone response in children with autistic disorder and irritability. J Child Adolesc Psychopharmacol 20:83-93
40. Lewin AB, Storch EA, Storch HD (2010) Risks from antipsychotic medications in children and adolescents. JAMA 303(8):729-730
41. Brosnan J, Healy O (2011) A review of behavioral interventions for the treatment of aggression in individuals with developmental disabilities. Res Dev Disabil 32:437-446
42. Masse J, McNeil CB, Wagner SM, Chorney DB (2007) Parent-child interaction therapy and high functioning autism: a conceptual overview. J Early Int Beh Interven 4:714-735
43. Posey DJ, Wiegand RE, Wilkerson J, Maynard M, Stigler KA, McDougle CJ (2006) Open-label atomoxetine for attention-deficit/hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders. J Child Adolesc Psychopharmacol 16(5):599-610
44. Zeiner P, Gjevik E, Weidle B (2011) Response to atomoxetine in boys with high-functioning autism spectrum disorders and attention deficit/hyperactivity disorder. Acta Paediatr 100:1258-1261
45. Troost PW, Steenhuis MP, Tuynman-Qua HG et al (2006) Atomoxetine for attention-deficit/hyperactivity disorder symptoms in children with pervasive developmental disorders: a pilot study. J Child Adolesc Psychopharmacol 16(5):611-619
46. Arnold LE, Aman MG, Cook AM et al (2006) Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial. J Am Acad Child Adolesc Psychiatry 45(10): 1196-1205
47. Goodman WK, Murphy TK, Storch EA (2007) Risk of adverse behavioral effects with pediatric use of antidepressants. Psychopharmacology 191(1):87-96
48. Fischer M, Barkley RA, Smallish L, Fletcher K (2005) Executive functioning in hyperactive children as young adults: attention, inhibition, response perseveration, and the impact of comorbidity. Dev Neuropsychol 27(1):107-133
49. Korenblum CB, Chen SX, Manassis K, Schachar RJ (2007) Performance monitoring and response inhibition in anxiety disorders with and without comorbid ADHD. Depress Anxiety 24(4):227-232
50. Barkley RA (1997) Defiant children: A clinician's manual for assessment and parent training. Guilford Press, New York
51. Kazdin AE (2003) Parent training and community-based interventions may benefit children with disruptive behaviour disorders. Evid Based Ment Health 6(3):81
52. Aman MG (2004) Management of hyperactivity and other acting-out problems in patients with autism spectrum disorder. Semin Pediatr Neurol 11(3):225-228
53. Brookman-Frazee L, Stahmer A, Baker-Ericzen MJ, Tsai K (2006) Parenting interventions for children with autism spectrum and disruptive behavior disorders: opportunities for cross-fertilization. Clin Child Fam Psychol Rev 9(3-4):181-200
54. Garland AF, Hawley KM, Brookman-Frazee L, Hurlburt MS (2008) Identifying common elements of evidence-based psychosocial treatments for children's disruptive behavior problems. J Am Acad Child Adolesc Psychiatry 47(5):505-514
55. van de Wiel N, Matthys W, Cohen-Kettenis PC, van Engeland H (2002) Effective treatments of schoolaged conduct disordered children: recommendations for changing clinical and research practices. Eur Child Adolesc Psychiatry 11(2):79-84